Laboratories planning infectious disease molecular testing need suppliers that can provide reliable PCR platforms, broad assay menus, and practical workflow support.
This shortlist reviews 10 molecular testing companies with infectious disease PCR portfolios and integrated workflow capabilities. The order does not indicate ranking. It is intended as a practical reference for laboratories, distributors, and public health programs evaluating PCR supplies.
10 Molecular Testing Companies at a Glance
| Company | Representative PCR Platform or Workflow | Representative Infectious Disease Coverage |
|---|---|---|
| Roche Diagnostics | cobas molecular systems, cobas eplex, and cobas liat | Virology (HIV, HBV, HCV), respiratory infections, sexual health (HPV, CT/NG), blood screening, and syndromic panel testing |
| Cepheid (Danaher) | GeneXpert systems and single-use Xpert cartridges | Respiratory infections, tuberculosis, healthcare-associated infections, gastrointestinal disease, and blood-borne virology |
| BioPerfectus | SAW Series automated nucleic acid extraction workstations, STC Series real-time PCR systems, and multiplex real-time PCR assay kits | Respiratory infections, vector-borne disease, gastrointestinal pathogens, zoonotic infections, blood-borne viruses, and emerging infections such as mpox |
| Abbott Molecular | Alinity m and Abbott RealTime m2000 | Blood-borne viruses (HIV, HBV, HCV), respiratory disease, sexually transmitted infections, and HPV testing |
| bioMérieux / BIOFIRE | BIOFIRE FILMARRAY TORCH and BIOFIRE SPOTFIRE | Multiplex syndromic panels for respiratory, gastrointestinal, bloodstream, central nervous system, and other infectious syndromes |
| QIAGEN | QIAstat-Dx, QIAstat-Dx Rise, and QIAsymphony workflows | Syndromic respiratory and gastrointestinal testing, nucleic acid purification, and integrated laboratory workflows for infectious disease |
| BD (Becton, Dickinson and Company) | BD MAX System | Respiratory pathogen panels, enteric pathogen testing, healthcare-associated infection assays, and women’s health / STI testing |
| Seegene | Allplex multiplex PCR assays with STARlet, STARlet-AIOS, and related automation | Multiplex real-time PCR for respiratory, gastrointestinal, sexually transmitted, and drug-resistant infections across broad assay menus |
| Thermo Fisher Scientific | Applied Biosystems real-time PCR instruments and TaqPath Menu assays | Respiratory pathogens, sexually transmitted infections, blood-borne infections, gastrointestinal disease, and transplant-associated viral monitoring |
| Sansure Biotech | Natch extraction systems, SLAN real-time PCR instruments, and iPonatic near-patient workstations | Respiratory tract infections, reproductive tract infections, blood-borne diseases, gastrointestinal infections, vector-borne pathogens, and public health testing programs |
Note: Companies are listed in no particular order.
1. Roche
Roche’s PCR ecosystem spans several laboratory models. The cobas 5800, 6800, and 8800 systems support automated testing in centralized molecular laboratories, while cobas eplex addresses multiplex syndromic testing and cobas liat brings automated PCR closer to the point of care.
Roche also offers LightCycler instruments and MagNA Pure purification systems for laboratories that need an open, configurable workflow. The portfolio combines standardized systems with configurable PCR components. This range can suit health systems seeking one supplier across high-volume, specialty, urgent, and near-patient testing.
2. Cepheid
Cepheid’s GeneXpert platform combines sample preparation, nucleic acid extraction, PCR amplification, and detection in a closed cartridge. Systems scale from compact configurations to GeneXpert Infinity models, while random access allows different Xpert assays to run together.
The test menu covers respiratory infections, tuberculosis and emerging diseases, gastrointestinal pathogens, healthcare-associated infections, blood virology, and sexual health. Cartridge-based testing also makes operator training and per-test inventory relatively easy to define. This model can help laboratories reduce manual steps and deploy a standardized workflow across central and decentralized sites.
3. BioPerfectus
BioPerfectus is a global, full-stack provider of molecular diagnostics and public health solutions, focusing on infectious diseases and women’s and children’s health. Its portfolio includes more than 700 diagnostic reagents and automated instruments, supported by 549 international market access certifications, with products available in over 100 countries and regions. For infectious disease laboratories, its range covers respiratory, vector-borne, gastrointestinal, zoonotic, and blood-borne pathogens. The company was among the early global companies to develop and commercialize SARS-CoV-2 PCR test reagents. It was also the first Chinese company to have a dengue rapid test included in the WHO ERPD list, and its mpox assays have been officially recommended by Africa CDC.
The company’s Total PCR Solution integrates SAW Series automated nucleic acid extraction workstations, SMPE/SSNP nucleic acid extraction systems, and STC Series real-time PCR instruments with dedicated software into a unified workflow, covering the entire process from sample pre-processing and nucleic acid extraction to amplification, detection, and result reporting.
4. Abbott
Abbott Molecular’s infectious disease portfolio centers on Alinity m and the Abbott RealTime m2000 workflow. Alinity m is an automated real-time PCR system with continuous loading and random-access operation.
Its menu includes assays for HIV-1, HBV, HCV, CMV, high-risk HPV, sexually transmitted infections, respiratory pathogens, and selected emerging infections, although availability differs by country. The platform can accommodate scheduled testing alongside time-sensitive samples. Abbott can be considered by laboratories that want consolidated routine molecular testing with integrated sample processing and amplification.
5. bioMérieux
bioMérieux’s BIOFIRE systems focus on syndromic PCR. BIOFIRE FILMARRAY TORCH provides a scalable platform for hospital laboratories, while BIOFIRE SPOTFIRE supports near-patient settings.
Available panels address respiratory, gastrointestinal, bloodstream, meningitis and encephalitis, pneumonia, joint, and tropical fever syndromes, depending on the market. Panel selection can be matched to the patient’s presenting syndrome and care setting. The approach tests multiple probable pathogens from one sample and can support laboratories that organize molecular testing around clinical syndromes rather than individual organisms.
6. QIAGEN
QIAGEN’s infectious disease portfolio includes both cartridge-based and modular workflows. QIAstat-Dx and QIAstat-Dx Rise automate multiplex syndromic testing, while QIAsymphony instruments support DNA and RNA purification and assay setup.
Rotor-Gene Q MDx and QIAcuityDx add real-time and digital PCR options for defined applications. This distinction helps buyers separate routine syndromic testing from specialized laboratory needs. The mix can serve laboratories that need a simplified sample-to-answer panel in one area and a configurable extraction and amplification workflow in another.
7. BD
The BD MAX System integrates nucleic acid extraction and real-time PCR on a benchtop platform. It can process different assays and sample types in the same run and supports both regulated IVD assays and open-system reagents for eligible laboratory-developed applications.
BD offers menus across enteric disease, respiratory infection, healthcare-associated infection, and women’s health. The platform can fit laboratories seeking mid-throughput automation with room to combine commercial tests and locally validated methods.
8. Seegene
Seegene’s Allplex portfolio uses multiplex real-time PCR to detect multiple pathogens within a single testing workflow. Menus cover respiratory and gastrointestinal infections, sexually transmitted infections, tuberculosis and resistance markers, and other infectious disease areas.
Compatible automation includes Seegene STARlet, STARlet-AIOS, STARlet 96MPH, and NIMBUS configurations, depending on the assay and region. Seegene can suit laboratories that prioritize broad multiplex menus, automated extraction, PCR setup, and interpretation.
9. Thermo Fisher Scientific
Thermo Fisher Scientific’s TaqPath Menu pairs infectious disease PCR kits with Applied Biosystems real-time PCR instruments, including supported QuantStudio and 7500 configurations.
The menu includes assays for respiratory pathogens, tuberculosis, sexually transmitted infections, blood-borne viruses, gastrointestinal pathogens, and infections affecting transplant recipients. Thermo Fisher also supplies master mixes, controls, plastics, and related PCR supplies. This breadth can help laboratories assemble open workflows or standardize components across assay development and routine testing.
10. Sansure
Sansure’s portfolio combines real-time PCR kits, extraction reagents, extraction instruments, PCR analyzers, and portable molecular workstations. Its infectious disease menu spans respiratory, reproductive tract, blood-borne, gastrointestinal, and vector-borne pathogens.
Natch systems support automated processing, SLAN instruments provide real-time PCR capacity, and iPonatic workstations integrate sample handling and amplification for decentralized use. Sansure can be relevant for buyers comparing conventional laboratory workflows with compact sample-to-result options, subject to local registration, service, and assay availability.
Key Considerations When Selecting an Infectious Disease PCR Partner
√ Assay Menu and Intended Use: Confirm that the target pathogens, applicable specimen types, and testing settings align with laboratory needs, including respiratory, gastrointestinal, blood-borne, sexually transmitted, vector-borne, and healthcare-associated infections.
√ Workflow and Testing Capacity: Review nucleic acid extraction, PCR testing, and automation configurations. Assess whether instrument throughput, batch-processing options, and hands-on requirements fit the laboratory’s operational needs.
√ Test Performance Documentation: Review validation data on the limit of detection, analytical specificity, cross-reactivity, precision, and clinical performance.
√ Regulatory Status and Market Access: Confirm that the product meets regulatory requirements in the intended market, such as FDA clearance, approval, or authorization; CE marking under the IVDR framework; or applicable local registration requirements.
√ Supply and Technical Support: Consider reagent storage and transport conditions, shelf life, supply continuity, technical service, and training support. Also confirm whether quality control and result traceability processes can integrate with existing laboratory workflows.
Conclusion
This shortlist presents a range of supplier options for infectious disease PCR testing across centralized laboratories, syndromic testing, decentralized settings, and public health programs. Molecular diagnostics company selection can be evaluated based on the required test menu, applicable specimen types, testing throughput, level of automation, local regulatory status, and the availability of reagents and technical support.
Sources:
[1] DataIntelo. Molecular Diagnostics in Infectious Disease Testing Market. Available at: https://dataintelo.com/report/global-molecular-diagnostics-in-infectious-disease-testing-market
[2] Mordor Intelligence. MOLECULAR DIAGNOSTICS MARKET SIZE & SHARE ANALYSIS – GROWTH TRENDS AND FORECAST (2026 – 2031). Available at: https://www.mordorintelligence.com/industry-reports/molecular-diagnostics-market
